Sandwich-cultured hepatocytes are most useful when the study question depends on polarized hepatocyte function rather than attachment alone. Plateable hepatocytes can be used in monolayer, sandwich-culture, and spheroid formats, but the sandwich configuration is specifically designed to support re-establishment of cellular polarity and formation of bile canaliculi-like networks.
That distinction matters for transporter and hepatobiliary studies. By coating the hepatocyte monolayer with collagen I or Matrigel on both sides, the culture creates an environment suited to biliary efflux and uptake transporter work, prolonged hepatic metabolism, drug-drug interaction (DDI) assessment, and investigation of mechanisms associated with chronic drug-induced liver injury (DILI).
| Practical decision rule: Choose sandwich culture when bile canaliculi, transporter function, hepatobiliary handling, or longer-duration hepatic behavior is central to the endpoint. For a suspended-cell metabolism or uptake workflow, suspension hepatocytes are a distinct format built around that use case. |
A sandwich culture starts with plateable primary hepatocytes and places extracellular matrix on both sides of the cell monolayer. Collagen I or Matrigel can be used for this configuration. The double-sided matrix environment promotes re-establishment of cellular polarity and the development of bile canaliculi-like networks.
The resulting culture is particularly relevant when a readout depends on directional transport across the hepatocyte and canalicular membrane. It also provides a practical format for studies that need more than a short suspended-cell incubation, including prolonged hepatic metabolism, DDI, and chronic DILI-related mechanisms.
Quick Reference: When Sandwich Culture Fits
| Endpoint | Use Sandwich Culture? | What to Confirm |
| Biliary efflux | Yes | Canalicular structure and transporter qualification. |
| Hepatobiliary excretion | Yes | Bile canaliculi formation and canalicular uptake evidence. |
| Uptake transporter studies | Yes, when a polarized plateable model is required | Transporter qualification and study-specific lot evidence. |
| Prolonged hepatic metabolism / DDI | Yes, when the study is designed around a plateable polarized model | Attachment, morphology, and relevant functional qualification. |
| Chronic DILI mechanisms | Yes | Plateable performance and a sandwich-culture design aligned with the intended mechanism. |
| Short suspended-cell metabolism / stability | No - use suspension hepatocytes | Metabolism qualification, enzyme activity, or stability data. |
| 3D culture endpoint | No - use 3D spheroid-qualified plateable hepatocytes | Spheroid qualification and culture duration. |
Bile canaliculi are central to hepatobiliary handling. In a sandwich configuration, polarized hepatocytes form canaliculi-like networks, making the model suitable for experiments focused on biliary efflux and hepatobiliary excretion.
Transporter studies often require a culture that preserves cellular polarity and a defined canalicular compartment. Sandwich-cultured hepatocytes are positioned for both biliary efflux and uptake drug transporter studies, while transporter-qualified plateable hepatocytes provide a functional selection option for these workflows.
When a DDI study is designed around plateable hepatocytes and requires polarized hepatic function, sandwich culture provides a relevant format. The same culture configuration is also used for evaluating prolonged hepatic metabolism.
Sandwich culture is also suited to studies investigating mechanisms of chronic drug-induced liver injury. The rationale is the combination of plateable hepatocytes, re-established polarity, and bile canaliculi-like structures within a longer-lived culture format.
If the experimental question includes direct confirmation of bile canaliculi formation or canalicular uptake, sandwich culture provides a visual and functional readout. This is especially useful when cell morphology and attachment alone are not sufficient to support the study endpoint.
In an SD rat plateable hepatocyte sandwich-culture example, the cells reached 100% confluency and formed bile canaliculi on day 3. CDFDA staining was observed within the bile canaliculi, providing a direct functional visualization of the canalicular network.
Figure 1. SD rat plateable hepatocytes in sandwich culture: 100% confluency and bile canaliculi formation on day 3 (A), with CDFDA uptake into bile canaliculi (B). The figure is presented on a white background without altering the microscopy data.
The culture format should follow the endpoint. Sandwich culture is not simply a more elaborate version of a monolayer; it answers a different set of questions. A practical selection framework is to start with the biological function the assay needs to preserve or measure.
| Study Need | Best-Aligned Format | Key Consideration |
| Metabolic activity or metabolic stability in a suspended-cell workflow | Suspension hepatocytes | Use a metabolism-qualified lot with relevant enzyme or substrate characterization. |
| Biliary efflux or hepatobiliary excretion | Plateable hepatocytes in sandwich culture | Look for transporter qualification, bile canaliculi formation, and canalicular uptake evidence. |
| Uptake transporter work requiring polarized plateable hepatocytes | Plateable hepatocytes in sandwich culture | Prioritize cellular polarity and transporter-qualified functional evidence. |
| Prolonged hepatic metabolism or DDI in a plateable model | Plateable hepatocytes in sandwich culture | Confirm attachment, morphology, and the qualification relevant to the planned endpoint. |
| 3D hepatocyte culture | 3D spheroid-qualified plateable hepatocytes | Use spheroid-specific qualification and the planned culture duration. |
| ASGPR-related workflows | ASGPR-qualified plateable hepatocytes | Review the post-recovery ASGPR characterization relevant to the intended timing. |
A sandwich-culture assay is only as useful as the biological configuration selected for the experiment. Before starting the study, align the product and lot with the planned species, donor configuration, qualification, and logistics.
1. Confirm the study endpoint. Define whether the assay is centered on biliary efflux, uptake transporters, hepatobiliary excretion, DDI, prolonged metabolism, or chronic DILI.
2. Confirm plateability and attachment-related performance. Plateable hepatocytes are characterized around high post-thaw viability, morphological integrity, and attachment efficiency.
3. Match the functional qualification. Transporter qualification is the most directly relevant option for sandwich-culture transporter studies; 3D spheroid and ASGPR qualification are separate pathways for different endpoints.
4. Select the biological configuration. Species, gender, pooled or single-donor availability, and cell specifications can be aligned with the study design.
5. Plan the logistics. Pack size, batch size, inventory status, and customization requirements should be resolved before the assay is scheduled.
6. Review lot-specific functional evidence where available. For transporter work, prioritize evidence that is directly connected to the readout you intend to measure.
MileCell plateable hepatocytes are available across a broad animal-species portfolio, including mouse, rat, dog, monkey, minipig, rabbit, feline, hamster, and guinea pig. The portfolio includes multiple mouse and rat strains, Beagle dog, Cynomolgus and Rhesus monkey, Bama minipig, New Zealand and Dutch-Belted rabbit, Chinese Domestic Cat, Maine Coon, LVG Hamster, and Hartley Guinea Pig. Human hepatocytes are also included in the overall hepatocyte availability portfolio.
Listed plateable animal products are supplied at 5 million cells per entry. Depending on the species and catalog entry, plateable products are presented as pooled or single-donor configurations, with male, female, or mixed-gender options where shown.
MileCell primary plateable hepatocytes support monolayer, sandwich-culture, and spheroid workflows for drug-development studies that include hepatotoxicity assessment, drug transport, hepatic drug metabolism, hepatobiliary excretion, and related applications. Product features include high post-thaw viability, morphological integrity and attachment efficiency, individual and pooled donor lots, broad species coverage, and configurable options for gender, species, pack size, batch size, and cell specifications.
· Transporter-qualified options for transporter and sandwich-culture workflows.
· 3D spheroid-qualified options for spheroid applications.
· ASGPR-qualified options for ASGPR-related workflows.
· Broad animal-species coverage and flexible donor configurations.
· Customization options for gender, species, pack size, batch size, and cell specifications.
| Next step: For a sandwich-culture study, start with the endpoint and request the plateable hepatocyte configuration and functional qualification that match the planned transporter, hepatobiliary, DDI, or chronic DILI workflow. |
They are used when the assay requires a polarized plateable hepatocyte model with bile canaliculi-like networks, including biliary efflux, uptake transporter studies, hepatobiliary excretion, prolonged hepatic metabolism, DDI, and mechanisms of chronic DILI.
The hepatocyte monolayer is coated with collagen I or Matrigel on both sides. This promotes re-establishment of cellular polarity and formation of bile canaliculi-like networks.
SD rat plateable hepatocytes reached 100% confluency and formed bile canaliculi on day 3, and CDFDA uptake was observed in the bile canaliculi.
Suspension hepatocytes are a separate format for drug metabolism and uptake studies in a suspended-cell workflow, including metabolic activity and metabolic-stability assessment.
No. They are separate plateable-hepatocyte formats. The 3D spheroid qualification example uses Cynomolgus monkey hepatocytes, with 3,000 cells forming spheroids of approximately 250–300 µm after 8 days.
Available options include gender, species, pack size, batch size, and cell specifications, with pooled or single-donor configurations depending on the product entry.
Use sandwich-cultured hepatocytes when the experimental endpoint depends on hepatocyte polarity, bile canaliculi, and transporter or hepatobiliary function. The format is particularly well aligned with biliary efflux and uptake transporter studies, hepatobiliary excretion, prolonged hepatic metabolism, DDI, and mechanistic work on chronic DILI.
The strongest workflow starts with the endpoint and then matches the plateable hepatocyte lot to the required species, donor configuration, attachment-related performance, and functional qualification. For transporter-focused work, direct evidence of canalicular structure and function should be part of that selection process.
Looking for plateable hepatocytes for transporter or DILI studies? Explore MileCell Primary Plateable Hepatocytes, request current product information and lot-specific characterization, or contact the MileCell team for technical support.
Contact: mailto:Info@milecell-bio.com | Website: www.milecell-bio.com